Delivery Order SPE2DB24D2205-SPE2DB25FEHLU
- Not listed
- The Defense Logistics Agency awarded a $1,109.00 delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. This contract award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price purchase with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a ceiling value of $1,976.82. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The work is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. This competitively awarded, non-set-aside contract carries a ceiling value of $1,493.80 and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Testosterone 1.62% (1.25 g) packets in unit doses, with a ceiling value of $3,806.18. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award to support federal medical procurement needs. The contract is performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, and is scheduled for ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,938.18 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,415.13 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. The contract employs firm fixed pricing with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,200.33 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packets. The contract is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and was competitively awarded without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,466.98 on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's ongoing...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Testosterone 1% (50 mg/5g) in unit dose 5-gram packets. This delivery order, valued at $1,112.22 with a firm fixed price structure, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award is non-competitive and designated for performance at the contractor's corporate...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHLUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams, with a ceiling value of $2,219.70 and a firm fixed price structure. This delivery order, which represents the ultimate completion date of September 12, 2025, was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its prime IDC with the Defense Logistics Agency. The company's extensive portfolio of federal contract awards demonstrates its capacity to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains, with consistent use of firm fixed pricing and delivery order mechanisms. This testosterone hormone treatment delivery supports the military healthcare supply chain and the broader Defense Health Agency mission to provision medical commodities for service members and beneficiaries worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/11/25 |